Compounds > 5-ethynyl-1-ribofuranosylimidazole-4-carboxamide
Page last updated: 2024-09-03

5-ethynyl-1-ribofuranosylimidazole-4-carboxamide and fluorouracil

5-ethynyl-1-ribofuranosylimidazole-4-carboxamide has been researched along with fluorouracil in 1 studies

Compound Research Comparison

Studies
(5-ethynyl-1-ribofuranosylimidazole-4-carboxamide)		Trials
(5-ethynyl-1-ribofuranosylimidazole-4-carboxamide)		Recent Studies (post-2010)
(5-ethynyl-1-ribofuranosylimidazole-4-carboxamide)		Studies
(fluorouracil)		Trials
(fluorouracil)		Recent Studies (post-2010) (fluorouracil)
210245,5629,30714,663

Protein Interaction Comparison

ProteinTaxonomy5-ethynyl-1-ribofuranosylimidazole-4-carboxamide (IC50)fluorouracil (IC50)
Epidermal growth factor receptorHomo sapiens (human)0.32
Thymidylate synthaseMus musculus (house mouse)1.58
AromataseHomo sapiens (human)0.63

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Matsuda, A; Minakawa, N1

Other Studies

1 other study(ies) available for 5-ethynyl-1-ribofuranosylimidazole-4-carboxamide and fluorouracil

ArticleYear
Mechanism-based design of inosine 5-monophosphate dehydrogenase inhibitors: synthesis and biological activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) and its derivatives.
    Current medicinal chemistry, 1999, Volume: 6, Issue:7

    Topics: Animals; Antineoplastic Agents; Catalysis; Drug Design; Fluorouracil; Humans; IMP Dehydrogenase; Inhibitory Concentration 50; Leukemia L1210; Models, Chemical; Ribavirin; Ribonucleosides; Structure-Activity Relationship; Tumor Cells, Cultured

1999